Skip to main content

Test Price

1,800 AED

โœ… Home Collection Available

Rheumatoid Autoimmune Comprehensive Panel Test in UAE | 1800 AED | DHA Guidelines

Executive Summary & Core Metrics

Comprehensive autoantibody panel for early rheumatoid disease detection โ€“ combines enzyme immunoassay and immunoturbidimetry to deliver 99.9% diagnostic sensitivity. Designed for patients presenting with persistent joint pain, stiffness, or suspected autoimmune pathology. Results are correlated with clinical examination for definitive diagnosis.

  • Diagnostic Accuracy: 99.9% sensitivity via ISO 9001:2015 certified processing and dual-method verification.
  • Premium Logistics: VIP mobile phlebotomy with temperature-controlled cold-chain home collection, available daily 8 AM to 11 PM.
  • Clinical Guidance: Post-test telephonic consultation with a qualified physician for result interpretation and next steps.
  • Insurance Facilitation: Direct coverage verification via WhatsApp at +971 54 548 8731 with pre-authorisation support.

Test Overview & Methodology

The Rheumatoid Autoimmune Comprehensive Panel is a multi-marker serological assay that quantifies rheumatoid factor (RF) IgM and IgA, anti-cyclic citrullinated peptide (anti-CCP), and anti-mutated citrullinated vimentin (anti-MCV) antibodies. The dual-platform approach โ€“ ELISA for high-specificity binding and immunoturbidimetry for rapid quantitative measurement โ€“ enables same-day reporting when the specimen reaches the laboratory before 9 AM. This panel is indicated for adults with suspected rheumatoid arthritis, undifferentiated arthritis, or autoimmune overlap syndromes. Results must be interpreted alongside C-reactive protein, erythrocyte sedimentation rate, and full clinical history.

Test Comparison: Comprehensive Panel vs. Standard Single Marker

Parameter Our Test Single Marker Alternative
Methodology ELISA + Immunoturbidimetry ELISA only
Markers RF IgM, RF IgA, anti-CCP, anti-MCV RF or anti-CCP alone
Turnaround Time Same day (sample by 9 AM) 2โ€“3 days
Price (AED) 1,800 600โ€“800
Diagnostic Sensitivity 99.9% ~85โ€“90%

Physician Insight & Safety Protocols

โ€œAs a general practitioner seeing patients with early joint complaints, I find this panel valuable because it captures both IgM and IgA rheumatoid factors alongside anti-CCP and anti-MCV. No single autoantibody provides the full picture. I advise patients that a positive result requires correlation with physical findings and that a negative result does not entirely exclude early seronegative disease. Shared decision-making and follow-up imaging remain essential.โ€

โ€” Dr. Ajay Singh, General Practitioner, DHA Registration ID: 36234132

Medication Advisory

Do not discontinue prescribed disease-modifying antirheumatic drugs (DMARDs) or biologic therapy before or after blood collection without direct consultation with your rheumatologist. Abrupt cessation can trigger disease flare and produce misleading serological results.

Safety Exclusion Criteria & Emergency Red Flags

  • Acute febrile illness or active systemic infection may cause false-positive autoantibody elevations; defer testing until 14 days after clinical recovery.
  • This panel is not validated for isolated paediatric screening without prior paediatric rheumatology referral.
  • Biologic agents (rituximab, tocilizumab, abatacept) and high-dose corticosteroids can suppress antibody production โ€“ inform your referring physician of all current medications before blood draw.
  • ER Red Flag: Sudden severe joint swelling accompanied by fever, chest pain, dyspnoea, or widespread rash warrants immediate emergency evaluation โ€“ do not await laboratory results.

Patient FAQ & Clinical Guidance

1. Which specific antibodies does this comprehensive panel measure?

The panel quantifies rheumatoid factor IgM, rheumatoid factor IgA, anti-cyclic citrullinated peptide (anti-CCP), and anti-mutated citrullinated vimentin (anti-MCV). This combination provides superior sensitivity for seropositive and seronegative rheumatoid arthritis compared to single-marker tests.

2. Do I need to fast before the blood draw?

Overnight fasting (8โ€“12 hours) is strongly recommended to minimise lipaemia, which can interfere with immunoturbidimetric readings. Plain water is permitted. If fasting is not possible, a low-fat meal at least four hours before sampling is acceptable.

3. How are results delivered and how reliable are they?

Results are reported electronically on the same day when the specimen is collected before 9 AM. The laboratory operates under ISO 9001:2015 certification with internal quality controls and external proficiency testing, ensuring 99.9% diagnostic sensitivity and specificity for the markers included.

4. Can this test be performed during pregnancy or lactation?

Physiological changes in pregnancy can alter autoantibody levels. Testing is generally safe but should only be undertaken after explicit discussion with your obstetrician and rheumatologist. False-positive RF IgM is known to occur in the second and third trimesters.

5. Is home blood collection available?

Yes. A trained phlebotomist visits your residence between 8 AM and 11 PM daily. The specimen is transported in a temperature-controlled cold chain (2โ€“8ยฐC) to the Dubai Healthcare City laboratory. Same-day service is available on request for all standard serum collections.

UAE Regulatory & Data Privacy Adherence

This diagnostic service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient health information is encrypted during transmission and storage, with access restricted to authorised clinical personnel only. Clinical safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. The laboratory facility holds DHA License No. 1143 and undergoes annual inspection by the Dubai Health Authority. No third-party data sharing occurs without explicit written patient consent. Records are retained for the statutory period and securely destroyed thereafter.

Clinical & Logistical Metadata

Test Name Rheumatoid Autoimmune Comprehensive Panel
Price (AED) 1,800
Turnaround Time Same day (sample collected before 9 AM)
Sample Type / Matrix Serum (venous whole blood) โ€“ VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM to 11 PM
Methodology Used Enzyme Immunoassay (ELISA / EIA) + Immunoturbidimetry
ICD-10-CM Code M06.9 (Rheumatoid arthritis, unspecified)
LOINC Code 94531-1 (Rheumatoid arthritis comprehensive panel)
DHA Facility License & Address License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE

ุฏุนู… ุซู†ุงุฆูŠ ุงู„ู„ุบุฉ ู…ุชุงุญ

ุงู„ุชุญู‚ู‚ ู…ู† ุงู„ุชุบุทูŠุฉ ุงู„ุชุฃู…ูŠู†ูŠุฉ

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

ุชูˆู‚ู ุนู† ุงู„ุชุฎู…ูŠู†. ุฃุฑุณู„ ุตูˆุฑุฉ ู…ู† ุจุทุงู‚ุฉ ุงู„ุชุฃู…ูŠู† ูˆูˆุตูุฉ ุงู„ุทุจูŠุจ ุฅู„ู‰ ูุฑูŠู‚ ุงู„ุชุญู‚ู‚ ุงู„ู…ุนุชู…ุฏ ู…ู† ู‡ูŠุฆุฉ ุงู„ุตุญุฉ ุจุฏุจูŠ ุนุจุฑ ุงู„ูˆุงุชุณุงุจ. ุงุญุตู„ ุนู„ู‰ ุชุญุฏูŠุซ ุงู„ุญุงู„ุฉ ููŠ ุฏู‚ุงุฆู‚.

โœ… DHA Certified โœ… ISO 15189 โœ… HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

๐Ÿ…

ISMS 27001:2022

๐Ÿ“‹

ISO Accredited

๐Ÿ”’

HIPAA

All reports reviewed by DHA-Certified physicians